The poster will be available on the publications page of the Apogee website on October 24. About ApogeeApogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with ...
Shares of architectural products and services company Apogee Enterprises (NASDAQ: APOG) rallied 25.5% on Friday, as of 2 p.m. ET. Apogee released second-quarter earnings today. Not only did the ...
Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest inflammatory and immunology (I&I) markets, ...
Marion Brooks will take a ‘strategic HR lead’ on the team and will head up the company’s people and culture function Managed print reseller Apogee has appointed chief people officer Marion Brooks onto ...
Apogee has appointed James Clark as its new chief executive officer, replacing outgoing CEO Aurelio Maruggi after almost four years. Clark (pictured) originally joined the managed workplace services ...
SAN FRANCISCO and WALTHAM, Mass., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with potential for ...